SUBSCRIBE
SUBSCRIBE

IPO

Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Deals
Current Climate The Best For Biotech IPOs In Decades, Says VC
October 20, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Largest Biotech IPO Yet Could Be Derailed By Forward Pharma, Biogen Idec Patent Fight
October 15, 2014
 · 
1 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Bay Area Biotech Dermira Increases Deal Size 46% To $117 Million
October 3, 2014
 · 
1 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
SF Biotech FibroGen, Inc. Plots $125 Million IPO As It Muscles Its Way Into Fibrosis
October 1, 2014
 · 
1 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Bay Area Biosimilar Firm Coherus Biosciences Eyes $86.25 Million IPO
September 26, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Swiss Biotech Firm Molecular Partners AG Plans $134 Million IPO
September 23, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Bay Area’s Dermira Supersizes IPO Up 30% To $98M
September 22, 2014
 · 
1 min read
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Deals
Fall Parade Of Biotech IPOs Sees Heavy Lineup
September 16, 2014
 · 
4 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
AbbVie-Backed Virobay Inc. Lines Up $50 Million IPO
September 11, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Global CRO PRA Health Sciences Files For $375 Million IPO As Clinical Trial Demand Heats Up
September 9, 2014
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Agomab Announces Closing of Initial Public Offering
February 10, 2026
 · 
4 min read
Press Releases
SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
February 10, 2026
 · 
3 min read
Press Releases
SpyGlass Pharma Announces Pricing of Initial Public Offering
February 6, 2026
 · 
3 min read
Press Releases
Agomab Announces Pricing of Initial Public Offering
February 6, 2026
 · 
4 min read
Press Releases
Veradermics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
February 6, 2026
 · 
2 min read
Press Releases
Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering
February 5, 2026
 · 
3 min read
Press Releases
Veradermics Announces Pricing of Upsized Initial Public Offering
February 4, 2026
 · 
4 min read
Press Releases
Agomab Announces Launch of Initial Public Offering
February 2, 2026
 · 
4 min read
Press Releases
Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
January 13, 2026
 · 
3 min read
Press Releases
Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025’s Largest Hong Kong Biotech IPO
December 30, 2025
 · 
12 min read
Press Releases
Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed
December 22, 2025
 · 
5 min read
Press Releases
Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 19, 2025
 · 
4 min read
Press Releases
Medline Announces Pricing of Upsized Initial Public Offering
December 17, 2025
 · 
4 min read
Press Releases
Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator
December 10, 2025
 · 
3 min read
Press Releases
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering
December 8, 2025
 · 
4 min read
Press Releases
Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering
December 4, 2025
 · 
4 min read
Press Releases
Lumexa Imaging Announces Launch of Initial Public Offering
December 2, 2025
 · 
2 min read
Press Releases
Hemostemix Closes CDN$280,594 Private Placement
November 19, 2025
 · 
1 min read
Press Releases
NervGen Pharma Announces US$10 Million Non-Brokered Private Placement to Support Anticipated Nasdaq Listing and Advance NVG-291 Development
November 19, 2025
 · 
1 min read
Press Releases
Veri Medtech (VRHI) Files Registration Statement for Proposed Initial Public Offering
November 18, 2025
 · 
5 min read
Load More